NEW YORK (GenomeWeb) – Canadian diagnostic developer GeneNews said today that it has signed a binding agreement with multinational private equity firm Milost Global for up to $10 million in equity and debt financing.

Under the agreement, Milost will initially purchase up to $3 million in unsecured convertible notes from GeneNews. The notes will be convertible at a price equal to the five-day volume-weighted average price of common shares of GeneNews on the Toronto Stock Exchange on the day of the draw-down notice, plus a 200 percent premium.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The Associated Press reports that the US government wasted $341,000 on travel by former Health and Human Services Secretary Tom Price.

Women who post YouTube science videos get more critical comments and more comments about their appearance than male video hosts, the New York Times reports.

The Wall Street Journal writes that participating in genetic research brings up the specter of past research ethics lapses for some African Americans.

In PLOS this week: sequences influencing yeast prion aggregation or degradation, dengue virus genetic variants affect transmission dynamics, and more.